Social Media Intervention for Cannabis Use in Emerging Adults

January 19, 2022 updated by: Erin Bonar, University of Michigan
The purpose of the study is to develop and test social media interventions to help young people increase well-being and reduce risky behaviors. The study will help researchers learn about ways to deliver wellness information in a way that is appealing and helpful to young people who use Facebook.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

149

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Michigan
      • Ann Arbor, Michigan, United States, 48109
        • University of Michigan

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 25 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • self-report using cannabis at least 3 time per week or more often in the past month
  • active Facebook profile
  • view and click on a social media ad

Exclusion Criteria:

  • fail identity verification based on 1) Internet Protocol (IP) addresses, 2) survey time completion, 3) repeat attempts, 4) survey responses, and 5) photo identification via a timestamped selfie sent to the research staff.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Social Media Intervention
Facebook page that will deliver health information focused on increasing well-being and reducing risky behaviors.
Information will be posted by e-coaches. You can interact with the e-coaches as well as other study members in your group.
No Intervention: Control
An Attention-Control E-News (control) condition

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frequency of Cannabis Use as Reported on the Timeline Follow-Back (TLFB)
Time Frame: 3-months post baseline
30-day TLFB self-report will be used to assess total number of days of cannabis use.
3-months post baseline
Frequency of Cannabis Use as Reported on the Timeline Follow-Back (TLFB)
Time Frame: 6-months post baseline
30-day TLFB self-report will be used to assess total number of days of cannabis use.
6-months post baseline
Quantity of Cannabis Used as Reported on the Timeline Follow-Back (TLFB)
Time Frame: 3-months post baseline
30-day Timeline Follow-Back (TLFB) self-report will be used to assess quantity (grams) of cannabis consumed.
3-months post baseline
Quantity of Cannabis Used as Reported on the Timeline Follow-Back (TLFB)
Time Frame: 6-months post baseline
30-day Timeline Follow-Back (TLFB) self-report will be used to assess quantity (grams) of cannabis consumed.
6-months post baseline
Consequences of Cannabis Use as Measured by the Marijuana Adolescent Consequences Questionnaire Using Dichotomous Response Scale as Previously Described Throughout This Trial Registration.
Time Frame: 3-months post-baseline

Marijuana Adolescent Consequences Questionnaire will be used to assess past 3 month consequences of cannabis use. Consequences are measured by report of number of times incidents from the list of 26 items (e.g., quality of work suffered, had less energy, etc.) resulted from cannabis use. Responses will be dichotomized (0 = never, 1= greater than never) and summed for a total score reflecting total number of consequences.

Response scale:

Never 1-2 times 3-5 times 6-10 times More than 10 times

Minimum score =0, maximum = 26. Higher score = more consequences.

3-months post-baseline
Consequences of Cannabis Use as Measured by the Marijuana Adolescent Consequences Questionnaire
Time Frame: 6-months post-baseline

Marijuana Adolescent Consequences Questionnaire will be used to assess past 3 month consequences of cannabis use. Consequences are measured by report of number of times incidents from the list of 26 items (e.g., quality of work suffered, had less energy, etc.) resulted from cannabis use. Responses will be dichotomized (0 = never, 1= greater than never) and summed for a total score reflecting total number of consequences.

Response scale:

Never 1-2 times 3-5 times 6-10 times More than 10 times

Minimum score =0, maximum = 26. Higher score = more consequences.

6-months post-baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perceived Risk of Cannabis Use as Measured by 2 Modified Items From the Monitoring the Future Survey
Time Frame: 3-months post-baseline

Two items rating current opinion on a scale from "no risk" to "great risk" of their perceived risk harm from occasional cannabis use and regular use.

Items are--

How much do you think people risk harming themselves (physically or in other ways), if they:

  1. Use marijuana or marijuana products occasionally
  2. Use marijuana or marijuana products regularly

Response options are:

  1. No risk
  2. Slight risk
  3. Moderate risk
  4. Great risk

Answers from both items are added together. The total range of two items summed can be 2-8. Higher totals indicate higher perceived risk.

3-months post-baseline
Perceived Risk of Cannabis Use as Measured by Modified Items From the Monitoring the Future Survey
Time Frame: 6-months post-baseline

Two items rating current opinion on a scale from "no risk" to "great risk" of their perceived risk harm from occasional cannabis use and regular use.

Items are--

How much do you think people risk harming themselves (physically or in other ways), if they:

  1. Use marijuana or marijuana products occasionally
  2. Use marijuana or marijuana products regularly

Response options are:

  1. No risk
  2. Slight risk
  3. Moderate risk
  4. Great risk

Answers from both items are added together. The total range of two items summed can be 2-8. Higher totals indicate higher perceived risk.

6-months post-baseline
Peer Approval/Disapproval of Cannabis Use as Measured by Item Modified From Monitoring the Future Survey
Time Frame: 3 months post-baseline

One item rating of current perception of whether their close friends would disapprove of their cannabis use (regardless of how much they use), rated as:

  1. Not disapprove
  2. Disapprove
  3. Strongly disapprove
3 months post-baseline
Peer Approval/Disapproval of Cannabis Use as Measured by Item Modified From Monitoring the Future Survey
Time Frame: 6 months post-baseline
One item rating of current perception of whether their close friends would disapprove of their cannabis use (regardless of how much they use), rated as: 1 Not disapprove 2 Disapprove 3 Strongly disapprove
6 months post-baseline
Cannabis Impaired Driving as Measured by 5 Items From the Modified Young Adult Driving Questionnaire
Time Frame: 3 months post-baseline

Five items from the modified Young Adult Driving Questionnaire will be used to assess past 3 month driving under the influence of cannabis. Response values will be summed for a total score.

In the PAST 3 MONTHS...how many times did you drive within one hour after using marijuana or marijuana products containing THC?

  • how many times did you drive while a little high on marijuana or marijuana products containing THC?
  • how many times did you drive while very high on marijuana or marijuana products containing THC?
  • how many times did you drive when you knew your use of marijuana/marijuana products containing THC may already have affected your coordination?
  • how many times did you ride in a car or other vehicle driven by someone who had been using marijuana or marijuana products containing THC?

Response options:

0= Never

  1. Once
  2. Twice
  3. 3 times
  4. 4 times
  5. 5 times
  6. 6-9 times
  7. 10 or more times
3 months post-baseline
Cannabis Impaired Driving as Measured by 5 Items From the Modified Young Adult Driving Questionnaire
Time Frame: 6 months post-baseline

Five items from the modified Young Adult Driving Questionnaire will be used to assess past 3 month driving under the influence of cannabis. Response values will be summed for a total score.

In the PAST 3 MONTHS...how many times did you drive within one hour after using marijuana or marijuana products containing THC?

  • how many times did you drive while a little high on marijuana or marijuana products containing THC?
  • how many times did you drive while very high on marijuana or marijuana products containing THC?
  • how many times did you drive when you knew your use of marijuana/marijuana products containing THC may already have affected your coordination?
  • how many times did you ride in a car or other vehicle driven by someone who had been using marijuana or marijuana products containing THC?

Response options:

0= Never

  1. Once
  2. Twice
  3. 3 times
  4. 4 times
  5. 5 times
  6. 6-9 times
  7. 10 or more times
6 months post-baseline
Other Drug Use as Measured by Items Modified From Monitoring the Future Survey
Time Frame: 3 months post-baseline

Items from the Monitoring the Future Survey will be used to assess past 30 day use of 6 other substances - substances used and number of times of use. Response values will be summed for a total score using mid-point of the range scoring.

Substances assessed include: hallucinogens, opioids, stimulants, sedatives, lsd, ecstasy

Response scale:

0 0 Occasions

  1. 1-2 Occasions
  2. 3-5 Occasions
  3. 6-9 Occasions
  4. 10-19 Occasions
  5. 20-39 Occasions
  6. 40 or More Occasions
3 months post-baseline
Other Drug Use as Measured by Items Modified From Monitoring the Future Survey
Time Frame: 6 months post-baseline

Items from the Monitoring the Future Survey will be used to assess past 30 day use of 6 other substances - substances used and number of times of use. Response values will be summed for a total score using mid-point of the range scoring.

Substances assessed include: hallucinogens, opioids, stimulants, sedatives, lsd, ecstasy

Response scale:

0 0 Occasions

  1. 1-2 Occasions
  2. 3-5 Occasions
  3. 6-9 Occasions
  4. 10-19 Occasions
  5. 20-39 Occasions
  6. 40 or More Occasions
6 months post-baseline
Frequency of Alcohol Consumption as Reported on the Timeline Follow-Back (TLFB)
Time Frame: 3 months post-baseline
30-day TLFB self-report will be used to assess total number of days of alcohol consumption.
3 months post-baseline
Frequency of Alcohol Consumption as Reported on the Timeline Follow-Back (TLFB)
Time Frame: 6 months post-baseline
30-day TLFB self-report will be used to assess total number of days of alcohol consumption.
6 months post-baseline
Quantity of Alcohol Consumption as Reported on the Timeline Follow-Back (TLFB)
Time Frame: 3 months post-baseline
30-day TLFB self-report will be used to assess the quantity of alcohol consumed.
3 months post-baseline
Quantity of Alcohol Consumption as Reported on the Timeline Follow-Back (TLFB)
Time Frame: 6 months post-baseline
30-day TLFB self-report will be used to assess the quantity of alcohol consumed.
6 months post-baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Erin Bonar, University of Michigan

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 3, 2020

Primary Completion (Actual)

December 18, 2020

Study Completion (Actual)

December 18, 2020

Study Registration Dates

First Submitted

December 3, 2019

First Submitted That Met QC Criteria

December 4, 2019

First Posted (Actual)

December 5, 2019

Study Record Updates

Last Update Posted (Actual)

February 11, 2022

Last Update Submitted That Met QC Criteria

January 19, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • HUM00152202
  • R34DA045712 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cannabis Use

Clinical Trials on Social Media Intervention

3
Subscribe